DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
BankPosition in GILD — Gilead Sciences, Inc.
CIK 1694217
FRANKFURT AM MAIN, 2M
Position in GILD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$295,879,581
+$45,143,243 QoQ
Shares Held
2,122,979
+3.9% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 41.35622632159809.ToString("F0")%
Shared 0.ToString("F0")%
None 58.643773678401914.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Mar 31, 2020CallValue
$6,728,400
CallShares
90,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main holds $6,138,982,939 across 11 Drug Manufacturers - General names. GILD ranks #4 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
12,938,604 | $2,551,751,478 | |
| 2 | JNJ |
Johnson & Johnson
|
6,172,828 | $1,508,886,072 | |
| 3 | LLY |
ELI LILLY & Co
|
1,263,243 | $1,161,893,009 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
2,122,979 | $295,879,581 | |
| 5 | ABBV |
AbbVie Inc.
|
1,091,285 | $237,343,571 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,705,178 | $205,115,859 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,163,953 | $70,593,748 | |
| 8 | AMGN |
Amgen Inc
|
186,559 | $65,640,782 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $295,879,581 | 2,122,979 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $250,736,338 | 2,042,825 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $206,911,992 | 1,864,072 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $60,037,432 | 541,512 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $59,749,539 | 533,240 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $27,717,832 | 300,074 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $31,336,037 | 373,760 | Shares | Defined | 2026-05-04 | |
| 2024-06-30 | $27,116,523 | 395,227 | Shares | Sole | 2026-05-04 | |
| 2024-03-31 | $21,448,918 | 292,818 | Shares | Defined | 2026-05-04 | |
| 2023-12-31 | $27,380,810 | 337,993 | Shares | Defined | 2026-05-04 | |
| 2023-09-30 | $25,963,861 | 346,462 | Shares | Defined | 2026-05-04 | |
| 2023-06-30 | $63,672,689 | 826,167 | Shares | Sole | 2026-05-04 | |
| 2023-03-31 | $100,281,522 | 1,208,648 | Shares | Sole | 2024-05-17 | |
| 2022-12-31 | $56,005,104 | 652,360 | Shares | Defined | 2024-05-17 | |
| 2022-09-30 | $33,193,166 | 538,064 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $35,617,640 | 576,244 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $38,992,837 | 655,893 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $33,826,093 | 465,860 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $58,954,934 | 844,022 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $48,094,369 | 698,437 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $15,780,639 | 244,169 | Shares | Defined | 2026-05-04 | |
| 2020-12-31 | $30,539,482 | 524,193 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $86,706,407 | 1,372,154 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $107,960,204 | 1,403,174 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $143,154,630 | 1,914,856 | Shares | Defined | 2020-05-15 | |
| 2020-03-31 | $6,728,400 | 90,000 | Call | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||